Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions
- PMID: 12093359
- DOI: 10.2174/1389200023337315
Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions
Abstract
Some carboxylic acid-containing drugs have been implicated in rare but serious adverse reactions. These compounds can be bioactivated via two distinct pathways: by UDP-glucuronosyltransferase-catalyzed conjugation with glucuronic acid, resulting in the formation of acyl glucuronides, or by acyl-CoA synthetase-catalyzed formation of acyl-CoA thioesters. This review compares the two types of potentially reactive metabolites with respect to their stability, protein-reactivity, target selectivity, and disposition in the liver, and summarizes the evidence which links acyl glucuronide and acyl-CoA thioester formation with downstream toxicologic effects. While with increasing drug concentration the acyl glucuronide pathway may prevail, CoA intermediates may be more reactive. Both metabolites are electrophilic species which can acylate target proteins if they escape inactivation by S-glutathione-thioester formation. A crucial factor is the up-concentration of acyl glucuronides in hepatocytes and the biliary tree, due to vectorial transport by conjugate export pumps, where they may selectively acylate canalicular membrane proteins. Furthermore, positional isomers, which are avidly formed by acyl migration, can glycate proteins in the liver and at more distal sites. In contrast, acyl-CoA esters may be more rapidly hydrolysed or further metabolized in hepatocytes, and their hepatobiliary transport has not been well explored. While there is accumulating evidence that acyl glucuronides can alter cellular function by various mechanisms, including haptenation of peptides, critical protein acylation or glycation, or direct stimulation of neutrophils and macrophages, the role of acyl-CoA intermediates is less clear. More work is needed to provide a causal link between protein-reactive acyl glucuronides and acyl-CoA thioesters and the rare and unpredictable idiosyncratic drug reactions in humans.
Similar articles
-
Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.Chem Res Toxicol. 2015 May 18;28(5):886-96. doi: 10.1021/tx500514z. Epub 2015 Apr 8. Chem Res Toxicol. 2015. PMID: 25803559
-
Metabolic activation of carboxylic acids.Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):425-38. doi: 10.1517/17425255.4.4.425. Expert Opin Drug Metab Toxicol. 2008. PMID: 18433345 Review.
-
Acyl glucuronide reactivity in perspective: biological consequences.Chem Biol Interact. 2003 May 6;145(2):117-37. doi: 10.1016/s0009-2797(03)00020-6. Chem Biol Interact. 2003. PMID: 12686489 Review.
-
Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites.Chem Res Toxicol. 2002 Oct;15(10):1309-17. doi: 10.1021/tx020013l. Chem Res Toxicol. 2002. PMID: 12387630
-
Acyl glucuronides: the good, the bad and the ugly.Biopharm Drug Dispos. 2010 Oct;31(7):367-95. doi: 10.1002/bdd.720. Biopharm Drug Dispos. 2010. PMID: 20830700 Review.
Cited by
-
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways.RSC Adv. 2018 Jan 3;8(3):1182-1190. doi: 10.1039/c7ra10533a. eCollection 2018 Jan 2. RSC Adv. 2018. PMID: 35540908 Free PMC article.
-
Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites.RSC Adv. 2020 Feb 3;10(9):5412-5427. doi: 10.1039/c9ra09115g. eCollection 2020 Jan 29. RSC Adv. 2020. PMID: 35498318 Free PMC article.
-
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.Int J Mol Sci. 2016 Oct 12;17(10):1714. doi: 10.3390/ijms17101714. Int J Mol Sci. 2016. PMID: 27754327 Free PMC article. Review.
-
Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profiling.RSC Adv. 2019 Feb 21;9(11):6409-6418. doi: 10.1039/c8ra10322d. eCollection 2019 Feb 18. RSC Adv. 2019. PMID: 35517257 Free PMC article.
-
Liquid chromatography-tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites.R Soc Open Sci. 2019 Aug 14;6(8):190852. doi: 10.1098/rsos.190852. eCollection 2019 Aug. R Soc Open Sci. 2019. PMID: 31598253 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical